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INTRODUCTION
Several respiratory diseases such as cystic fibrosis, chronic bronchitis and bronchiectasis are characterized by the increased production and accumulation of mucus secretion in the airways, predisposing these patients to recurrent infections throughout life, contributing to airway and parenchymal damage. Airway clearance therapy (ACT) has been a cornerstone in respiratory therapy for the treatment of pulmonary hypersecretion 1 .
There are several techniques of ACT, and some of them such as the slow expiration with glottis opened in lateral posture (ELTGOL, an acronym from the French term l'expiration lente totale glotte ouverte en decubitus lateral), autogenic drainage (AD), active cycle of breathing technique (ACBT) and oral high-frequency oscillation (OHFO) devices can be performed by the patient. In clinical practice, ELTGOL, AD and ACBT require a better understanding of the patient and a longer period of respiratory therapy to promote the intended effect. Additionally, the OHFO devices for secretion clearance are an increasingly used alternative to traditional treatments, being well accepted by patients and allow nonsupervised use 2 , including by adolescents and children 3 .
Besides being portable and practical to assist in daily bronchial hygiene and promote greater independence for the treatment, these devices improve adherence to respiratory therapy 4 . OHFO devices combine two physiological effects: a positive expiratory pressure and vibrations transmitted through the airways that facilitate the removal of secretions and expectoration 5 . Flutter VRP1 (designed by Lindemann 6 and produced by Axcan Scandipharm Inc., Birmingham, Alabama, USA) and the Shaker (a prototype developed by the NCS Indústria e Comércio, São Paulo, São Paulo, Brazil) are OHFO devices that are commercially available with the same vibration mechanism. Both devices have the shape of a smoking pipe and consist of four parts: (1) a body with a mouthpiece; (2) a conical cavity; (3) a stainless steel sphere; and (4) a protective cap through which expired air flows. The stainless steel sphere provides resistance to exhaled air, opening and closing the air passage and producing pressure oscillations. Simultaneously, it produces a vibration at approximately 15Hz, compatible with those necessary for the removal of secretions 2 .
OHFO devices promote these benefits but also have disadvantages such as the cost, which is a barrier especially for patients with lower socioeconomic status or those from developing countries. In Brazil, the Flutter VRP1 and Shaker devices cost approximately US$ 50 and US$ 20, respectively. Based on this concern, we describe the development of a low-cost OHFO device for bronchial hygiene similar to those commercially available and compare their physical properties.
METHODOLOGY
This was an experimental study conducted in two phases. In the first phase, we built an oral high-frequency oscillation (OHFO) device with low-cost materials. In the second phase, the physical properties (oscillation frequencies and positive pressures) were evaluated in a laboratory.
Phase 1: development of a low cost OHFO device (OHFO-LC)
Materials and assembly: we used the materials below to develop a OHFO-LC: an 0.8 inch length and 3/4 inch diameter polyvinyl chloride (PVC) pipe (A), a 5/8 inch diameter stainless steel sphere (B), a 3/4 inch diameter PVC elbow (C) and a 2 inch length and 3/4 inch diameter PVC pipe (D), as showed in Figure 1 .
Polyvinyl chloride (PVC) was chosen because it is an inert and nontoxic low-cost plastic that is malleable, allowing it to be easily molded 7 . The dimensions of the PVC pieces were defined based on the approximate dimensions of the other two OHFO devices we compared in our study. The stainless steel sphere, however, is approximately twice the size of the stainless steel sphere of the other two OHFO devices. This difference is due to the sphere sitting: the Flutter VRP1 and the Shaker spheres sit in a circular cone inside the bowl of the pipe, while the sphere of the OHFO-LC remains in the elbow of a 3/4 inch diameter PVC pipe. The mouthpiece of the OHFO-LC device was molded with a 2 inch length and 3/4 inch diameter PVC pipe by immersing one side in 100°C water for approximately 30 seconds. Then, a resin mold (2 inch length, 0.75 inch width, 0.3 inch height) was inserted inside the latter PVC pipe piece, following an immersion into cold water (approximately 0°C) to cool the material. At last, the resin mold was removed, standardizing the vertical opening in the mouthpiece to 0.3 inch. The 0.8 inch long PVC piece aims at preventing the escape of the steel sphere. Two 0.2 inch holes were drilled in this piece, symmetrically and diametrically opposed, with the aid of a drill. These holes facilitate the removal of this PVC piece to enable the cleaning of the equipment. The assembly of the portable equipment was designed to fit part A into part C after the introduction of part B (sphere) at one free end of part C. Finally, part D was fitted to the other free end of part C, as showed in Figure 1 . A punctuated orifice was drilled on the right side of every OHFO mouthpiece devices (OHFO-LC, Shaker, and Flutter VRP1), in which a transducer (Validyne DP 45-28-2114) was fitted to quantify the pressure. The airflow sent into the OHFOs was introduced by means of an elastic tube attached in the mouthpiece on one side and in an oxygen cylinder on the other side. A pneumotachograph (Validyne DP 45-16-2114) was attached between the cylinder and the mouthpiece to measure the airflow, as showed in Figure 2 .
The pressure and flow transducers recorded values in a physiograph (Gould RS 3400). The data were only collected after the airflow was maintained constant through each mouthpiece at 4, 6, 8 10 and 15 L/min. These air flow rates are within the range used by Volsko, DiFiore and Chatburn 8 . The flow and pressure transducers were previously calibrated. We obtained the data using a 12-channel analog-to-digital converter with a sampling frequency of 100 Hz (DT 2801a, Data Translation) and stored the data on a microcomputer. All the measurements were obtained with the devices at an angle of zero degrees, relative to the workstation.
The oscillation frequencies were estimated as the average number of cycles obtained during the pressure analysis for every airflow set (from 4 to 15 L/min). All devices were analyzed during the same period, and the values were expressed as cycles per second. The pressure values were obtained using the Anadat 3.1 software. Data normality was assessed by the Kolmogorov-Smirnov test. Data were presented as the means and standard deviations. The mean frequencies and positive pressures among the groups were compared using oneway analysis of variance (Anova) with Tukey post-hoc tests. We adopted a 5% significance level.
RESULTS
The OHFO-LC final cost was approximately US$ 3 (US$ 0.5 for the polyvinyl chloride (PVC) material and US$ 2.5 for the stainless steel sphere). This cost is at least 6 times lower than the Shaker (NCS, Brazil) (US$ 20) and over 15 times lower than the Flutter (Axcan Scandipharm Inc., USA) (US$ 50).
There was no difference in the mean frequencies between the OHFO-LC, Shaker and Flutter at any of the tested flow rates (4 L/min: 13.8±0.1, 11.7±0. 
DISCUSSION
Our study showed the development of a low-cost handheld device (OHFO-LC) for airway clearance therapy (ACT) and demonstrated that it promoted a similar frequency but a higher positive expiratory pressure than those observed in oral high-frequency oscillation (OHFO) devices commercially available. Based on our findings, OHFO-LC could be considered for use in clinical practice and could be an option for patients with lower income.
We achieved our initial objective of developing a lowcost OHFO device, with a final cost of approximately US$ 3. This cost is at least 6 times lower than the cost of the Shaker (NCS, Brazil) and over 15 times lower than that of the Flutter (Axcan Scandipharm Inc., USA). We emphasize that the cost of our equipment can be further reduced, especially if the spheres were purchased in larger quantities. We tried to replace the stainless steel sphere with iron spheres, which is cheaper; however, it oxidized after constant use and cleaning the sphere, hindering the hygiene of the equipment. It is important for ACT devices to avoid contamination to minimize the risk of infection.
Spheres manufactured from materials lighter than steel such as aluminum or Teflon (a type of plastic) do not reach the same pressure levels as the original stainless steel sphere in the Flutter VRP1 9 . The OHFO-LC was built using polyvinyl chloride (PVC) because it is a low-cost, inert, nontoxic and malleable material 7 . Malleability is essential to allow the molding of the mouthpiece.
The ACT has been widely used in a variety of acute and chronic conditions, especially in patients with pulmonary hypersecretion 10 , to increase the quantity of expectorated mucus, prevent infections of the respiratory tract, and improve pulmonary function [11] [12] [13] . Thus, techniques allowing self-management for patients with hypersecretion are essential to the patient's independence in daily care [14] [15] [16] and the need for hospital outpatient services. There are several techniques of ACT, but only few are considered appropriate for self-management (the slow expiration with glottis opened in lateral posture, the active cycle of breathing technique, the autogenic drainage and the OHFO devices). Among them, OHFO devices are being increasingly used 14 and have some advantages such as portability, good acceptance by the patient, and applicability for non-supervised use 2 , including by adolescents and children 3 .
OHFO devices vibrate during the expiration, which mobilizes mucus 17 . The oscillatory frequencies in the commercially available OHFOs range from 12 to 15 Hz, which is a similar to the physiological ciliary beat 18, 19 ; therefore, this vibration provides an optimal mucociliary clearance. Our results show that the frequency of the Shaker and Flutter ranged between 11.7 and 15.5Hz. OHFO-LC reached a similar frequency in all expiratory flows, showing similarity to the commercially available devices.
Positive expiratory pressure (PEP) is another important physiological effect in the OHFOs because it retains the air in the lung for a prolonged period, avoiding the collapse of the lung alveoli, improving the gaseous exchange and mobilizing secretion 16, 20 . The PEP obtained using the OHFO-LC was higher when compared with the Shaker and Flutter VRP1, as showed in Figure 4 . We think this may be a consequence of the weight of the stainless steel sphere, which is heavier when compared with the Shaker and Flutter (respectively, 42g vs. 30g and 28g). The higher PEP may be more beneficial due to air trapping reduction and facilitates the displacement of secretion in the airways.
Thompson et al. 21 reported the patient's preference for using the OHFO when compared with the active cycle breathing technique. Moreover, a Cochrane review 22 showed that patients from 10 out of the 29 studies reported a preference for self-management airway clearance techniques. Patient's preference may improve their adherence to the treatment and induce greater benefits. Another Cochrane review indicated that increased adherence to a bronchial hygiene therapy may lead to improvements in clinical and functional parameters such as exercise tolerance and respiratory function 17 .
Our study has limitations. First, the airflow rates ranged from 4-15 L/min due to measurement limitation of our experimental flow meter. However, that range is in the protocol used by Volsko, DiFiore and Chatburn 8 (5-30 L/min), which performed the comparison of two oscillating expiratory positive pressure devices: Flutter vs Acapella. Second, previous studies 1,2 compared the effects of the Shaker and Flutter and both have an internal cone to support the steel sphere, enabling device inclination; that is not the case in the OHFO-LC and the three devices were only compared at an angle of 0° (parallel to the floor). On the other hand, this did not prevent OHFO-LC from reaching frequencies similar to those of the ciliary beat. We also consider that the assembly of the OHFO-LC requires the use of specific tools such as a drill, demanding caution when handling. At last, our results are preliminary since it is important to better understand the physiological effects of a novel device before exposing it to the patient.
Finally, a low-cost handheld OHFO device for the self-management of bronchial hypersecretion was developed and evaluated, showing similar frequencies and higher expiratory pressures than other commercially available OHFO devices. Further studies are necessary to evaluate its clinical efficacy.
